Sony Biotechnology Inc. Sustainability Profile
Sony Biotechnology Inc., a subsidiary of the renowned Sony Corporation, is headquartered in the United States and operates globally, with a strong presence in key markets across Europe and Asia. Founded in 2015, the company has quickly established itself in the biotechnology industry, focusing on innovative solutions for cell analysis and sorting. Specialising in advanced flow cytometry systems, Sony Biotechnology offers unique products that enhance research capabilities in life sciences. Their flagship technologies, such as the SH800S cell sorter, are designed to provide high-performance, user-friendly solutions that cater to both academic and clinical research needs. With a commitment to quality and innovation, Sony Biotechnology has garnered recognition for its contributions to the field, positioning itself as a leader in the biotechnology sector. The company continues to push the boundaries of scientific research, making significant strides in cellular analysis and diagnostics.
DitchCarbon Score
How does Sony Biotechnology Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sony Biotechnology Inc.'s score of 86 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sony Biotechnology Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sony Group Corporation, which cascades its climate commitments and emissions data down to its subsidiaries. As part of its parent company's sustainability initiatives, Sony Group Corporation has set ambitious climate targets, including commitments to reduce greenhouse gas emissions across its operations. These initiatives are aligned with the Science Based Targets initiative (SBTi) and include participation in various climate pledges such as RE100 and the Climate Pledge. While specific reduction targets for Sony Biotechnology Inc. are not detailed, the overarching goals from Sony Group Corporation aim to achieve significant reductions in Scope 1, 2, and 3 emissions. The company is actively working towards enhancing its sustainability practices and reducing its carbon footprint in line with industry standards. In summary, while specific emissions data for Sony Biotechnology Inc. is not available, the company is committed to sustainability through its affiliation with Sony Group Corporation, which has established comprehensive climate commitments and reduction targets.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 891,486,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Sony Biotechnology Inc.'s Industry?
How Carbon Intensive is Sony Biotechnology Inc.'s Location?
Sony Biotechnology Inc.'s Scope 3 Categories Breakdown
Sony Biotechnology Inc.'s Scope 3 emissions, which decreased by 15% last year and increased by approximately 4% since 2018, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 60% of Scope 3 emissions.
Top Scope 3 Categories
Sony Biotechnology Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sony Biotechnology Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
